Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IronIC: IV Iron for Iron Deficiency in Heart Transplant Recipients
NCT03662789Phase 3Completed
- Sponsor
- Oslo University Hospital
- Start
- Apr 2018
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
A Phase 3 trial of ferric derisomaltose in iron deficiency anemia (IDA), sponsored by Oslo University Hospital. Started Apr 2018; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03662789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03662789.